Advanced Search
Contact | Corporate | Help

TARCEVA (Erlotinib) in Combination With Chemoradiation in Patients With Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC)

Sponsors:
  • M.D. Anderson Cancer Center
  • Genentech
  • Department of Defense
Phases:
  • Phase II
IndicationsAcronym:
  • Non-small Cell Lung Cancer
  • Lung Cancer
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: Erlotinib
  • Drug: Carboplatin
  • Drug: Paclitaxel
Enrollment:
72

Additional information about NCT00563784.


SourceSolution © 2008-2012